Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.6623
-0.0373 (-5.33%)
At close: Apr 14, 2026, 4:00 PM EDT
0.6381
-0.0242 (-3.65%)
Pre-market: Apr 15, 2026, 7:30 AM EDT
Impact BioMedical Revenue
In the year 2025, Impact BioMedical had annual revenue of $32.00K. Impact BioMedical had revenue of $7.00K in the quarter ending December 31, 2025.
Revenue (ttm)
$32.00K
Revenue Growth
n/a
P/S Ratio
2,231.56
Revenue / Employee
$16,000
Employees
2
Market Cap
71.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 50.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pelthos Therapeutics | 16.80M |
| BeyondSpring | 1.88M |
| Rani Therapeutics Holdings | 1.63M |
| Coeptis Therapeutics Holdings | 1.36M |
| NRx Pharmaceuticals | 1.23M |
| MediciNova | 409.66K |
| iBio, Inc. | 300.00K |
| InflaRx | 34.44K |
IBO News
- 11 days ago - Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans - GlobeNewsWire
- 8 months ago - Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 10 months ago - Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger - GlobeNewsWire
- 1 year ago - Impact Biomedical Inc. Announcement Stock Activity/Pricing - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. to Present at The Microcap Conference - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire